Berkeley Lights Stock
Cell Manipulation for Personalized Therapies
About Berkeley Lights Stock
Berkeley Lights is a provider of research and development services using micro-droplet technology intended to fundamentally change the way biological processes are done. The company's services revolutionize how scientists and researchers study the interaction of cells and transform and accelerate cellular therapies, enabling clients to meet the demands for cell based processes in biotherapeutic discovery and development, cellular therapy manufacturing, synthetic biology, ag-bio and other fields.
Investors
AJS Investments
Atinum Investment
Black Diamond Ventures
Cota Capital
KTB Network
Paxion Capital Partners
Katerra, Innovium, Berkeley Lights, H2O.ai, Bossa Nova Robotics
Sequoia Capital
OYO, Airbnb, DoorDash, Instacart, Stripe, Moderna Therapeutics, Nubank, Rappi, Bird, Dropbox
Shangbay Capital
Varian
Walden Riverwood Ventures
Funding History
| August 2011 | $183K |
|---|---|
| April 2012 | $500K |
| August 2012 | $4.0M |
| July 2014 | $29.2M |
| April 2015 | $58.6M |
| November 2016 | $40.0M |
| June 2018 | $95.0M |
Management
Chief Executive Officer
Eric Hobbs
Chief Financial Officer
Shaun Holt
Chief Technology Officer
Keith Breinlinger
Chief Scientific Officer
Kevin Chapman
Press
GlobeNewswire - May, 12 2020
PR Newswire - Apr, 27 2020
San Francisco Business Times - Mar, 13 2020
PR Newswire - Mar, 9 2020
PR Newswire - Feb, 28 2020
PR Newswire - Jan, 2 2020
fiercebiotech - Oct, 1 2019
synbiobeta - Sep, 16 2019
finance - Sep, 5 2019
prnewswire - Aug, 7 2019
prnewswire - Jun, 10 2019
bioportfolio - May, 18 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Berkeley Lights or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
